The standard semaglutide protocol increases the dose every 4 weeks, but some patients benefit from staying at a lower dose for 68 weeks before advancing
Fella understands that creating a positive experience with GLP-1 therapy is critical to patient success
This matters for researchers who prioritize data over novelty
For instance, due to its effects on the nitric oxide pathway and vascular function, it should be carefully assessed when used alongside anticoagulants, vasodilators, or certain gastrointestinal medications
Clinical Oversight & Safety Board-certified physicians and nurse practitioners will conduct all medical evaluations
[18] [19] Whilst these benefits likely result from multiple mechanismsincluding weight loss, blood pressure reduction, and anti-inflammatory effectsimprovements in lipid profiles may contribute to the overall cardiovascular protection observed